Literature DB >> 32929754

Systemic amyloidosis from A (AA) to T (ATTR): a review.

E Muchtar1, A Dispenzieri1, H Magen2, M Grogan3, M Mauermann4, E D McPhail5, P J Kurtin5, N Leung1,6, F K Buadi1, D Dingli1, S K Kumar1, M A Gertz1.   

Abstract

Systemic amyloidosis is a rare protein misfolding and deposition disorder leading to progressive organ failure. There are over 15 types of systemic amyloidosis, each caused by a different precursor protein which promotes amyloid formation and tissue deposition. Amyloidosis can be acquired or hereditary and can affect various organs, including the heart, kidneys, liver, nerves, gastrointestinal tract, lungs, muscles, skin and soft tissues. Symptoms are usually insidious and nonspecific resulting in diagnostic delay. The field of amyloidosis has seen significant improvements over the past decade in diagnostic accuracy, prognosis prediction and management. The advent of mass spectrometry-based shotgun proteomics has revolutionized amyloid typing and has led to the discovery of new amyloid types. Accurate typing of the precursor protein is of paramount importance as the type dictates a specific management approach. In this article, we review each type of systemic amyloidosis to provide the practitioner with practical tools to improve diagnosis and management of these rare disorders.
© 2020 The Association for the Publication of the Journal of Internal Medicine.

Entities:  

Keywords:  Apo-A; amyloidosis; diagnosis; heart failure; mass spectrometry

Year:  2020        PMID: 32929754     DOI: 10.1111/joim.13169

Source DB:  PubMed          Journal:  J Intern Med        ISSN: 0954-6820            Impact factor:   8.989


  17 in total

1.  AL Lambda Amyloidosis Activates Acute Liver Failure in the Absence of Plasma Cell Dyscrasia.

Authors:  Nilofar Najafian; Andrew T Weber; Jonathan E Zuckerman; Sarah Zhang; Sammy Saab; Gina Choi
Journal:  Dig Dis Sci       Date:  2021-10-15       Impact factor: 3.199

2.  Position Statement on Diagnosis and Treatment of Cardiac Amyloidosis - 2021.

Authors:  Marcus V Simões; Fabio Fernandes; Fabiana G Marcondes-Braga; Philip Scheinberg; Edileide de Barros Correia; Luis Eduardo P Rohde; Fernando Bacal; Silvia Marinho Martins Alves; Sandrigo Mangini; Andréia Biolo; Luis Beck-da-Silva; Roberta Shcolnik Szor; Wilson Marques Junior; Acary Souza Bulle Oliveira; Márcia Waddington Cruz; Bruno Vaz Kerges Bueno; Ludhmila Abrahão Hajjar; Aurora Felice Castro Issa; Felix José Alvarez Ramires; Otavio Rizzi Coelho Filho; André Schmidt; Ibraim Masciarelli Francisco Pinto; Carlos Eduardo Rochitte; Marcelo Luiz Campos Vieira; Cláudio Tinoco Mesquita; Celso Dario Ramos; José Soares-Junior; Minna Moreira Dias Romano; Wilson Mathias Junior; Marcelo Iório Garcia Junior; Marcelo Westerlund Montera; Marcelo Dantas Tavares de Melo; Sandra Marques E Silva; Pedro Manoel Marques Garibaldi; Aristóteles Comte de Alencar Neto; Renato Delascio Lopes; Diane Xavier de Ávila; Denizar Viana; José Francisco Kerr Saraiva; Manoel Fernandes Canesin; Glaucia Maria Moraes de Oliveira; Evandro Tinoco Mesquita
Journal:  Arq Bras Cardiol       Date:  2021-09       Impact factor: 2.000

Review 3.  Cardiac amyloidosis-interdisciplinary approach to diagnosis and therapy.

Authors:  A Hänselmann; D Berliner; J Bauersachs; U Bavendiek
Journal:  Herz       Date:  2022-06-08       Impact factor: 1.740

Review 4.  Dynamic protein structures in normal function and pathologic misfolding in systemic amyloidosis.

Authors:  Emily Lewkowicz; Olga Gursky
Journal:  Biophys Chem       Date:  2021-10-14       Impact factor: 3.628

5.  Amyloid arthropathy in smoldering myeloma: Do not take it lightly.

Authors:  Eli Muchtar; Rebecca L King; Ellen D McPhail; Matthew P Thorpe; Wilson Gonsalves; Floranne Ernste; Martha Grogan; Angela Dispenzieri; Morie A Gertz
Journal:  Leuk Res Rep       Date:  2021-04-24

6.  Patient and family experience with transthyretin amyloid cardiomyopathy (ATTR-CM) and polyneuropathy (ATTR-PN) amyloidosis: results of two focus groups.

Authors:  David Rintell; Dena Heath; Florencia Braga Mendendez; Elizabeth Cross; Theodore Cross; Vincent Knobel; Bruno Gagnon; Cameron Turtle; Alan Cohen; Edward Kalmykov; Jonathan Fox
Journal:  Orphanet J Rare Dis       Date:  2021-02-08       Impact factor: 4.123

Review 7.  Amyloid Formation by Globular Proteins: The Need to Narrow the Gap Between in Vitro and in Vivo Mechanisms.

Authors:  Giulia Faravelli; Valentina Mondani; P Patrizia Mangione; Sara Raimondi; Loredana Marchese; Francesca Lavatelli; Monica Stoppini; Alessandra Corazza; Diana Canetti; Guglielmo Verona; Laura Obici; Graham W Taylor; Julian D Gillmore; Sofia Giorgetti; Vittorio Bellotti
Journal:  Front Mol Biosci       Date:  2022-02-14

8.  Pulmonary 99mTc-HMDP uptake correlates with restrictive ventilatory defects and abnormal lung reactance in transthyretin cardiac amyloidosis patients.

Authors:  Astrid Monfort; Alexia Rivas; Rishika Banydeen; Jocelyn Inamo; Karim Farid; Remi Neviere
Journal:  Respir Res       Date:  2022-03-27

9.  Machine Learning Quantification of Amyloid Deposits in Histological Images of Ligamentum Flavum.

Authors:  Andy Y Wang; Vaishnavi Sharma; Harleen Saini; Joseph N Tingen; Alexandra Flores; Diang Liu; Mina G Safain; James Kryzanski; Ellen D McPhail; Knarik Arkun; Ron I Riesenburger
Journal:  J Pathol Inform       Date:  2022-02-08

10.  Negative Fat Pad Biopsy in Systemic AL: A Case Report Analyzing the Preferred Amyloidosis Screening Test.

Authors:  Kelsey Hummel; Hany Meawad; William T Gunning; Amira F Gohara
Journal:  Diseases       Date:  2021-05-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.